[CLINICAL EXPERIENCES WITH ENDOXAN].
D003520:Cyclophosphamide; D040181:Genetic Diseases, X-Linked; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D007943:Leukemia, Hairy Cell; D007945:Leukemia, Lymphoid; D008206:Lymphatic Diseases; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009369:Neoplasms / Q000628:therapy*; D010954:Plasmacytoma; D012509:Sarcoma; D016511:Severe Combined Immunodeficiency
D003520:Cyclophosphamide
CYCLOPHOSPHAMIDE; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; NEOPLASM THERAPY; PLASMACYTOMA; RETICULOENDOTHELIOSIS; SARCOMA, RETICULUM CELL
KLINISCHE ERFAHRUNGEN MIT ENDOXAN.